Posts With Tag Phase 1 clinical trial

Compugen Ltd. filed a Form 6-K on January 8, 2025, detailing the first patient dosed in a Phase 1 trial for COM503. This pivotal update could impact investor confidence and market position.

Explore Radiopharm Theranostics Limited's December 2024 report detailing RAD 202's Phase 1 trial approval, reflecting key developments in their therapeutic pipeline and compliance status.